arGEN-X appoints Alain Thibault CMO
This article was originally published in Scrip
Preclinical-stage antibody company arGEN-X has appointed Dr Alain Thibault chief medical officer. Prior to joining arGEN-X, Dr Thibault was therapeutic area head of oncology at Regeneron Pharmaceuticals, and his previous career included senior research positions at Johnson & Johnson and Roche. In addition, arGEN-X has appointed Dr Jacobus Rasser, previously senior partner at IP law firm Howrey, IP counsel.